Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and FGFR1 rearrangement. Yan Y, Qu S, Liu J, Li C, et al. Leuk Lymphoma 2023;64:1605-1610.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yan Y, Qu S, Liu J, Li C, et al. Olverembatinib for myeloid/lymphoid neoplasm associated with eosinophilia and FGFR1 rearrangement. Leuk Lymphoma 2023;64:1605-1610.
PMID: 37354441